- Home
- KALV vs MGPI Comparison
KALV vs MGPI Comparison
Compare KALV & MGPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALV
- MGPI
- Stock Information
- Founded
- KALV N/A
- MGPI 1941
- Country
- KALV United States
- MGPI United States
- Employees
- KALV N/A
- MGPI N/A
- Industry
- KALV Biotechnology: Pharmaceutical Preparations
- MGPI Beverages (Production/Distribution)
- Sector
- KALV Health Care
- MGPI Consumer Staples
- Exchange
- KALV Nasdaq
- MGPI Nasdaq
- Market Cap
- KALV 637.9M
- MGPI 672.4M
- IPO Year
- KALV N/A
- MGPI 1988
- Fundamental
- Price
- KALV $12.34
- MGPI $27.45
- Analyst Decision
- KALV Strong Buy
- MGPI Strong Buy
- Analyst Count
- KALV 9
- MGPI 5
- Target Price
- KALV $26.29
- MGPI $45.40
- AVG Volume (30 Days)
- KALV 1.0M
- MGPI 223.1K
- Earning Date
- KALV 09-04-2025
- MGPI 07-31-2025
- Dividend Yield
- KALV N/A
- MGPI 1.75%
- EPS Growth
- KALV N/A
- MGPI N/A
- EPS
- KALV N/A
- MGPI N/A
- Revenue
- KALV N/A
- MGPI $609,404,000.00
- Revenue This Year
- KALV N/A
- MGPI N/A
- Revenue Next Year
- KALV $192.67
- MGPI N/A
- P/E Ratio
- KALV N/A
- MGPI N/A
- Revenue Growth
- KALV N/A
- MGPI N/A
- 52 Week Low
- KALV $7.30
- MGPI $25.12
- 52 Week High
- KALV $16.32
- MGPI $92.52
- Technical
- Relative Strength Index (RSI)
- KALV 36.00
- MGPI 38.26
- Support Level
- KALV $12.19
- MGPI $27.35
- Resistance Level
- KALV $14.35
- MGPI $28.91
- Average True Range (ATR)
- KALV 0.61
- MGPI 1.22
- MACD
- KALV -0.30
- MGPI -0.31
- Stochastic Oscillator
- KALV 5.26
- MGPI 10.14
About KALV KalVista Pharmaceuticals Inc.
KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.
About MGPI MGP Ingredients Inc.
MGP Ingredients Inc is a producer and supplier of premium distilled spirits and specialty wheat protein and starch food ingredients. MGP also produces high-quality industrial alcohol for use in both food and non-food applications. It operates in three segments: Distillery Solutions, Branded Spirits Segment, and Ingredient Solutions. Distillery Solutions provides distillery co-products, such as distillers feed, fuel grade alcohol, and corn oil: and warehouse services, including barrel put away, storage, and retrieval services. It derives its revenue from the Distillery Solutions segment.